193
Views
7
CrossRef citations to date
0
Altmetric
Original Article

Prevalence and prognostic value of hepatic histological alterations in patients with Crohn’s disease

, , , , , , , , & show all
Pages 1463-1468 | Received 03 Jun 2015, Accepted 15 Jun 2015, Published online: 02 Jul 2015

References

  • Sands BE. From symptom to diagnosis: clinical distinctions among various forms of intestinal inflammation. Gastroenterology 2004;126:1518–32.
  • Bernstein CN, Blanchard JF, Rawsthorne P, Yu N. The prevalence of extraintestinal diseases in inflammatory bowel disease: a population-based study. Am J Gastroenterol 2001;96:1116–22.
  • Rankin GB, Watts HD, Melnyk CS, Kelley MLJr. National Cooperative Crohn’s Disease Study: extraintestinal manifestations and perianal complications. Gastroenterology 1979;77:914–20.
  • Su CG, Judge TA, Lichtenstein GR. Extraintestinal manifestations of inflammatory bowel disease. Gastroenterol Clin North Am 2002;31:307–27.
  • Adriani A, Pantaleoni S, Luchino M, Ribaldone DG, Reggiani S, Sapone N, et al. Osteopenia and osteoporosis in patients with new diagnosis of inflammatory bowel disease. Panminerva Med 2014;56:145–9.
  • Colìa R, D’Onofrio F, Cantatore FP. Ulcerative colitis and systemic lupus erythematosus. Minerva Med 2013;104:579–81.
  • Hugot JP, Laurent-Puig P, Gower-Rousseau C, Olson JM, Lee JC, Beaugerie L, et al. Mapping of a susceptibility locus for Crohn’s disease on chromosome 16. Nature 1996;379:821–3.
  • Silverberg MS, Mirea L, Bull SB, Murphy JE, Steinhart AH, Greenberg GR, et al. A population- and family-based study of Canadian families reveals association of HLA DRB1*0103 with colonic involvement in inflammatory bowel disease. Inflamm Bowel Dis 2003;9:1–9.
  • Langmann T, Moehle C, Mauerer R, Scharl M, Liebisch G, Zahn A, et al. Loss of detoxification in inflammatory bowel disease: dysregulation of pregnane X receptor target genes. Gastroenterology 2004;127:26–40.
  • Ardizzone S, Puttini PS, Cassinotti A, Porro GB. Extraintestinal manifestations of inflammatory bowel disease. Dig Liver Dis 2008;40:S253–9.
  • Navaneethan U, Shen B. Hepatopancreatobiliary manifestations and complications associated with inflammatory bowel disease. Inflamm Bowel Dis 2010;16:1598–19.
  • Gizard E, Ford AC, Bronowicki JP, Peyrin-Biroulet L. Systematic review: The epidemiology of the hepatobiliary manifestations in patients with inflammatory bowel disease. Aliment Pharmacol Ther 2014;40:3–15.
  • Loftus EVJr, Sandborn WJ, Tremaine WJ, Mahoney DW, Zinsmeister AR, Offord KP, et al. Primary sclerosing cholangitis is associated with non-smoking – a case-control study. Gastroenterology 1996;110:1496–502.
  • Caviglia GP, Touscoz GA, Smedile A, Pellicano R. Noninvasive assessment of liver fibrosis: key messages for clinicians. Pol Arch Med Wewn 2014;124:329–35.
  • Pontes RM, Muarrek FJ, Strauss E, Guembarowski AM. [Hepatic changes in patients with nonspecific ulcerative colitis]. [Article in Portuguese]. Arq Gastroenterol 1995;32:48–53.
  • Pellicano R, Bonardi R, Smedile A, Saracco G, Ponzetto A. Lagget M, et al. [Gastroenterology outpatient clinic of the Molinette Hospital (Turin, Italy): the 2003-2006 report]. [Article in Italian]. Minerva Med 2007;98:19–23.
  • Knodell RG, Ishak KG, Black WC, Chen TS, Craig R, Kaplowitz N, et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1981;1:431–5.
  • Sandrin L, Fourquet B, Hasquenoph JM, Yon S, Fournier C, Mal F, et al. Transient elastography: a new noninvasive method for assessment of hepatic fibrosis. Ultrasound Med Biol 2003;29:1705–13.
  • Roulot D, Czernichow S, Le Clésiau H, Costes JL, Vergnaud AC, Beaugrand M. Liver stiffness values in apparently healthy subjects: influence of gender and metabolic syndrome. J Hepatol 2008;48:606–13.
  • Actis GC, Pellicano R, Fadda M, Rosina F. Antibiotics and non-steroidal anti-inflammatory drugs in outpatient practice: indications and unwanted effects in a gastroenterological setting. Curr Drug Saf 2014;9:133–7.
  • de Lédinghen V, Vergniol J. Transient elastography (FibroScan). Gastroenterol Clin Biol 2008;32:58–67.
  • Castera L, Forns X, Alberti A. Non-invasive evaluation of liver fibrosis using transient elastography. J Hepatol 2008;48:835–47.
  • Brühl J, Schirren M, Wei C, Antoni C, Böcker U. Prospective noninvasive analysis of hepatic fibrosis in patients with Crohn’s disease: correlation of transient elastography and laboratory-based markers. Eur J Gastroenterol Hepatol 2011;23:923–30.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.